Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recurrent dysgerminoma after 33 years.

I E Haines, M A Schwarz, R A Sinclair

    The Australian & New Zealand Journal of Obstetrics & Gynaecology
    |May 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    MIF-CD74 signaling impedes microglial M1 polarization and facilitates brain tumorigenesis.

    Oncogene·2016
    Same author

    Methods for retrovirus-mediated gene transfer to fetal lung.

    Methods in molecular medicine·2014
    Same author

    Definition of K(trans) and FA thresholds for better assessment of experimental glioma using high-field MRI: a feasibility study.

    Clinical neuroradiology·2013
    Same author

    Hypothesis. The importance of a histological diagnosis when diagnosing and treating advanced cancer. Famous patient recovery may not have been from metastatic disease.

    Internal medicine journal·2011
    Same author

    An approximate model for cancellous bone screw fixation.

    Computer methods in biomechanics and biomedical engineering·2011
    Same author

    Are guidelines on use of colony-stimulating factors in solid cancers flawed?

    Internal medicine journal·2009

    Ovarian pure dysgerminoma has high cure rates with surgery and radiotherapy. This case highlights a rare late recurrence 33 years post-treatment, emphasizing the need for long-term patient follow-up.

    Area of Science:

    • Gynecologic Oncology
    • Reproductive Endocrinology

    Background:

    • Localized pure dysgerminoma of the ovary typically shows high cure rates with standard treatment.
    • Recurrence of ovarian dysgerminoma usually occurs within two years of initial management.

    Observation:

    • A 58-year-old woman, para 1, presented with recurrent pure dysgerminoma.
    • The recurrence was diagnosed 33 years after her initial surgery for the same condition.

    Findings:

    • This case represents an exceptionally late recurrence of ovarian pure dysgerminoma.
    • The typical 2-year recurrence window was significantly exceeded.

    Implications:

    • Long-term surveillance is crucial for patients treated for ovarian pure dysgerminoma.

    Related Experiment Videos

  • Extended follow-up protocols may be warranted to detect rare late relapses.